Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Kristine Peterson

Kristine Peterson is recorded as Board Member at ArriVent BioPharma, Inc. (AVBP) and Board Member at Immunocore Holdings plc (IMCR). Kristine Peterson was last confirmed as Board Member at Enanta Pharmaceuticals Inc (ENTA) in a filing dated January 26, 2024. Earlier roles on record: Board Member at EyePoint, Inc. (EYPT) until December 31, 2020. ArriVent BioPharma, Inc. reported in an 8-K filed April 22, 2024 that Kristine Peterson was appointed Class III Director, effective April 20, 2024.

“On April 20, 2024, the Board of Directors (the "Board") of ArriVent BioPharma, Inc. (the "Company") appointed Kristine Peterson to the Board, effective immediately (the "Effective Date").”
ArriVent BioPharma, Inc. Form 8-K, filed April 22, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at ArriVent BioPharma, Inc.

Other people whose current roles at this company are on record from its filings.

Leadership on record at Immunocore Holdings plc

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.